NCT07620990 Mindfulness Meditation in Hemodialysis Patients
| NCT ID | NCT07620990 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cyprus Aydin University |
| Condition | Hemodialysis |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-04-15 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-04-15 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomised controlled study aims to evaluate the effects of mindfulness meditation on sleep quality, perceived stress and symptoms levels ion hemodialysis patients. Participants in the intervention group will receive a 4 week mindfulness meditation program in addition to routine care. Outcomes will be assessed before and after the intervention using validated measurement tools.
Eligibility Criteria
Inclusion Criteria: * Patients aged between 18 and 75 years * Patients receiving hemodialysis treatment for at least 3 months * Patients with cognitive functions suitable for the intervention (dementia score ≥21) * Patient without hearing, vision or communication problems * Patients without a psychiatric diagnosis * Patients able to use a smartphone or tablet * Patients not participating in another study * Patients not using sleep medication or antipsychotic drugs Exclusion Criteria: * Patients younger than 18 years or older than 75 years * Patients receiving hemodialysis treatment for less than 3 months * Patients with cognitive impairment unsuitable for the intervention (dementia score ≤21) * Patient with hearing, vision or communication disabilities * Patients diagnosed with psychiatric disorders * Patients unable to use a smartphone or tablet * Patients participating in another study * Patients using sleep medication or antipsychotic drugs
Contact & Investigator
Sevda Sahin, RN, PhD Candidate
PRINCIPAL INVESTIGATOR
Cyprus Aydin University
Frequently Asked Questions
Who can join the NCT07620990 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Hemodialysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07620990 currently recruiting?
Yes, NCT07620990 is actively recruiting participants. Contact the research team at sevda0584@hotmail.com for enrollment information.
Where is the NCT07620990 trial being conducted?
This trial is being conducted at Famagusta, Cyprus, Kyrenia, Cyprus, Lefka, Cyprus, Nicosia, Cyprus.
Who is sponsoring the NCT07620990 clinical trial?
NCT07620990 is sponsored by Cyprus Aydin University. The principal investigator is Sevda Sahin, RN, PhD Candidate at Cyprus Aydin University. The trial plans to enroll 50 participants.